Advertisement

Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling

02:19 EDT 18th June 2013 | BioPortfolio

Summary

Primary purpose :To early detect cardiac allograft vasculopathy and to identify patients with high risk of cardiac events, by coupling the analysis of the kinetics of the brain natriuretic peptide ( BNP) with that of the left ventricle (LV) during a dobutamine stress echocardiography.

Hypothesis : Plasma BNP elevation and abnormalities of LV kinetic during the ESD, will be associated with the presence of allograft vasculopathy and the arisen of cardiovascular events.

Study Design

Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic

Conditions

Vasculopathy

Intervention

Dobutamine stress echocardiography, coronarography, brachial arterial echography

Location

Service de Physiologie et d'Explorations Fonctionnelles, Hôpital Civil, Hôpitaux Universitaires de Strasbourg
Strasbourg
France
67091

Status

Recruiting

Source

University Hospital, Strasbourg, France

Results (where available)

View Results

Links

Medical and Biotech [MESH] Definitions

Ankle Brachial Index

Comparison of the BLOOD PRESSURE between the BRACHIAL ARTERY and the POSTERIOR TIBIAL ARTERY. It is a predictor of PERIPHERAL ARTERIAL DISEASE.

Echocardiography, Three-dimensional

Echocardiography amplified by the addition of depth to the conventional two-dimensional ECHOCARDIOGRAPHY visualizing only the length and width of the heart. Three-dimensional ultrasound imaging was first described in 1961 but its application to echocardiography did not take place until 1974. (Mayo Clin Proc 1993;68:221-40)

Echocardiography, Stress

A method of recording heart motion and internal structures by combining ultrasonic imaging with exercise testing (EXERCISE TEST) or pharmacologic stress.

Peripheral Arterial Disease

Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Brachial Plexus Neuritis

A syndrome associated with inflammation of the BRACHIAL PLEXUS. Clinical features include severe pain in the shoulder region which may be accompanied by MUSCLE WEAKNESS and loss of sensation in the upper extremity. This condition may be associated with VIRUS DISEASES; IMMUNIZATION; SURGERY; heroin use (see HEROIN DEPENDENCE); and other conditions. The term brachial neuralgia generally refers to pain associated with brachial plexus injury. (From Adams et al., Principles of Neurology, 6th ed, pp1355-6)

Clinical Trials [ 777 Associated Clinical Trials listed on BioPortfolio]

Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization

To define the role of the assessment of myocardial viability with dobutamine echocardiography (DE) in the clinical evaluation and selection of the best treatment for a high-risk subset of...

Imaging Modalities in Detection of Coronary Artery Disease in End-Stage Renal Disease Patients

This study investigates hypothesizes that the combination of dobutamine stress echocardiography with dobutamine stress echocardiography with real time perfusion myocardial contrast echocar...

Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging

The present study is designed to: 1. investigate the safety and efficacy of Real time myocardial echocardiography (RT-MCE) in adolescents and adults ages 13-40 with congenital and...

Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection

While cardiac resynchronization therapy (CRT) has a well demonstrated therapeutic effect in selected patients with advanced heart failure (HF) on optimized drug therapy, non-responder rate...

Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regade...

PubMed Articles [ 11648 Associated PubMed Articles listed on BioPortfolio]

The Value of β-Blockers Administration during Recovery Phase of Dobutamine Stress Echocardiography: A Review.

Dobutamine stress echocardiography (DSE) is a successful technique for detection of ischemia in patients with suspected coronary artery disease (CAD). There are some data that administration of β-blo...

Beta Adrenergic Receptor Blockade Causing Severe Left Ventricular Systolic Dysfunction during Dobutamine Stress Echocardiography in a Patient with No Structural Heart Disease.

A 41-year-old woman with a history of neurocardiogenic syncope treated with beta-blockers was admitted with chest pain. Dobutamine echocardiogram images demonstrated decreased global LV systolic wall...

Target heart rate to determine the normal value of coronary flow reserve during dobutamine stress echocardiography.

ABSTRACT: BACKGROUND: The determination of coronary flow reserve (CFR) is an essential concept at the moment of decision-making in ischemic heart disease. There are several direct and indirect tests t...

Mitral Valve Regurgitation: Paradoxical Behavior of Dobutamine Stress Cardiac Magnetic Resonance Imaging.

A 62-year-old woman with mitral regurgitation (MR) underwent cardiac magnetic resonance (CMR) and dobutamine stress CMR imaging, a widely used method to analyze left ventricular function and MR volume...

Can ischemia and dyssynchrony be detected during early stages of dobutamine stress echocardiography by 2-dimensional speckle tracking echocardiography?

Strain and strain rate (SR) measured with 2-dimensional speckle tracking echocardiography (2-D STE) can quantitatively assess myocardial function. Our aim was to evaluate whether we could detect abnor...

More From BioPortfolio on "Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling"

Search BioPortfolio: